Medicure Inc. (CVE:MPH – Get Free Report)’s share price crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$0.92 and traded as low as C$0.88. Medicure shares last traded at C$0.88, with a volume of 2,700 shares trading hands.
Medicure Stock Down 1.1 %
The company has a market cap of C$9.08 million, a price-to-earnings ratio of -3.48 and a beta of 0.90. The business has a fifty day moving average of C$0.92 and a two-hundred day moving average of C$0.99. The company has a current ratio of 1.87, a quick ratio of 1.29 and a debt-to-equity ratio of 2.06.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- Which Wall Street Analysts are the Most Accurate?
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Stock Splits, Do They Really Impact Investors?
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
